Richard Nolan Townsend
CIK: 0001995218
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Lexeo Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Sep 24, 2026LXEO
Lexeo Therapeutics, Inc.
Award(A)DirectStock Option (right to buy)
145.5K shares- - Sep 14, 2026LXEO
Lexeo Therapeutics, Inc.
Award(A)Direct2.3K shares at avg. $2.64$6K - Aug 18, 2026LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct3.3K shares at avg. $4.95$17K - Jul 1, 2026LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct25.9K shares at avg. $4.48$116K - Jun 29, 2026LXEO
Lexeo Therapeutics, Inc.
Award(A)Direct67K shares- - May 18, 2026LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct3.3K shares at avg. $5.06$17K - Apr 6, 2026LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct55K shares at avg. $5.69$313K - Mar 13, 2026LXEO
Lexeo Therapeutics, Inc.
Award(A)Direct2.6K shares at avg. $2.64$7K - Feb 18, 2026LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct10.2K shares at avg. $6.38$65K - Feb 4, 2026LXEO
Lexeo Therapeutics, Inc.
Award(A)Direct161.7K shares- - Nov 18, 2025LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct1.1K shares at avg. $9.27$10K - Oct 17, 2025LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct148 shares at avg. $9.56$1K - Oct 17, 2025LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct13K shares at avg. $8.94$116K - Oct 15, 2025LXEO
Lexeo Therapeutics, Inc.
Award(A)Direct33K shares- - Sep 12, 2025LXEO
Lexeo Therapeutics, Inc.
Award(A)Direct2.2K shares at avg. $2.64$6K - Aug 18, 2025LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct1.1K shares at avg. $4.67$5K - Aug 18, 2025LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct2.7K shares at avg. $4.67$13K - May 16, 2025LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct1.1K shares at avg. $2.77$3K - Mar 14, 2025LXEO
Lexeo Therapeutics, Inc.
Award(A)Direct2.1K shares at avg. $2.61$6K - Feb 19, 2025LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct4.3K shares at avg. $4.41$19K - Jan 7, 2025LXEO
Lexeo Therapeutics, Inc.
Award(A)Direct103.8K shares- - Dec 10, 2024LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct2.5K shares at avg. $8.20$20K - Dec 10, 2024LXEO
Lexeo Therapeutics, Inc.
Exercise(M)Direct2.5K shares at avg. $2.33$6K - Nov 11, 2024LXEO
Lexeo Therapeutics, Inc.
Exercise(M)Direct2.5K shares at avg. $2.33$6K - Nov 11, 2024LXEO
Lexeo Therapeutics, Inc.
Sale(S)Direct2.5K shares at avg. $7.82$20K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 24, 2026 | LXEO Lexeo Therapeutics, Inc. | Award(A) Stock Option (right to buy) | 145,500 | - | - | Direct |
| Sep 14, 2026 | LXEO Lexeo Therapeutics, Inc. | Award(A) | 2,306 | $2.64 | $6,097 | Direct |
| Aug 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 3,345 | $4.95 | $16,562 | Direct |
| Jul 1, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 25,947 | $4.48 | $116,243 | Direct |
| Jun 29, 2026 | LXEO Lexeo Therapeutics, Inc. | Award(A) | 67,000 | - | $0 | Direct |
| May 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 3,342 | $5.06 | $16,927 | Direct |
| Apr 6, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 55,000 | $5.69 | $313,137 | Direct |
| Mar 13, 2026 | LXEO Lexeo Therapeutics, Inc. | Award(A) | 2,623 | $2.64 | $6,935 | Direct |
| Feb 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 10,173 | $6.38 | $64,924 | Direct |
| Feb 4, 2026 | LXEO Lexeo Therapeutics, Inc. | Award(A) | 161,665 | - | $0 | Direct |
| Nov 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 1,127 | $9.27 | $10,447 | Direct |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 148 | $9.56 | $1,415 | Direct |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 12,985 | $8.94 | $116,021 | Direct |
| Oct 15, 2025 | LXEO Lexeo Therapeutics, Inc. | Award(A) | 33,000 | - | - | Direct |
| Sep 12, 2025 | LXEO Lexeo Therapeutics, Inc. | Award(A) | 2,193 | $2.64 | $5,798 | Direct |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 1,115 | $4.67 | $5,205 | Direct |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 2,735 | $4.67 | $12,767 | Direct |
| May 16, 2025 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 1,074 | $2.77 | $2,979 | Direct |
| Mar 14, 2025 | LXEO Lexeo Therapeutics, Inc. | Award(A) | 2,128 | $2.61 | $5,554 | Direct |
| Feb 19, 2025 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 4,326 | $4.41 | $19,091 | Direct |
| Jan 7, 2025 | LXEO Lexeo Therapeutics, Inc. | Award(A) | 103,750 | - | $0 | Direct |
| Dec 10, 2024 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 2,500 | $8.20 | $20,491 | Direct |
| Dec 10, 2024 | LXEO Lexeo Therapeutics, Inc. | Exercise(M) | 2,500 | $2.33 | $5,825 | Direct |
| Nov 11, 2024 | LXEO Lexeo Therapeutics, Inc. | Exercise(M) | 2,500 | $2.33 | $5,825 | Direct |
| Nov 11, 2024 | LXEO Lexeo Therapeutics, Inc. | Sale(S) | 2,500 | $7.82 | $19,557 | Direct |
1-25 of 29 transactions
About Townsend Richard Nolan
Townsend Richard Nolan (SEC CIK 0001995218) files insider reports with the SEC as Chief Executive Officer of Lexeo Therapeutics, Inc. (LXEO).
Signal8 holds 21 ownership filings by Townsend Richard Nolan, all Form 4s, filed between Sep 11, 2024 and Sep 28, 2026. Those filings report 29 transactions, from Sep 10, 2024 to Sep 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Townsend Richard Nolan's filings is in NEW YORK, NY.
Recent filings by Townsend Richard Nolan
- Sep 24, 2026: Grant or award of LXEO derivative securities (Form 4, code A).
- Sep 14, 2026: Grant or award of LXEO shares (Form 4, code A).
- Aug 18, 2026: Open-market sale of LXEO shares (Form 4, code S).
- Jul 1, 2026: Open-market sale of LXEO shares (Form 4, code S).
- Jun 29, 2026: Grant or award of LXEO shares (Form 4, code A).
Other insiders filing for Lexeo Therapeutics, Inc. (LXEO)
- Tamayo Louis Edward, Chief Financial Officer
- Bhalla Narinder Pal, Chief Medical Officer
- Otero Jose Manuel, Chief Operating Officer
- Altschuler Steven, Director
- Agger Mette Kirstine, Director
- COOPERSTONE BRENDA, Director